QA: Seelos Therapeutics INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2024_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 5,403,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 15,000
4 LiabilitiesCurrent 38,928,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,626,389
9 ResearchAndDevelopmentExpense 36,158,673
10 remainder_Expenses 0
11 remainder_Revenues 1,429,977
12 remainder_NetIncome 1,356,239
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,418,000
1 Liabilities 38,928,000
2 Expenses 48,785,062
3 Revenues 1,429,977
4 StockholdersEquity -33,510,000
5 NetIncome -45,998,846
6 ComprehensiveNetIncome -45,998,846
7 BaseVar 47,958,639
8 EconomicCapitalRatiobeforeLimitedLiability -5.37
9 EconomicCapitalRatio 0.141

Edgar->Model Mapping

Feature Distribution

Change over Time